CASTLE BIOSCIENCES, INC. Increase (Decrease) in Employee Related Liabilities
CASTLE BIOSCIENCES, INC. (CSTL) reported Increase (Decrease) in Employee Related Liabilities of -$11.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was $7.78M, a 9.36% increase year-over-year.
- CASTLE BIOSCIENCES, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$19.18M.
- CASTLE BIOSCIENCES, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was $6.52M, a 33.61% increase year-over-year.
- CASTLE BIOSCIENCES, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $6.79M, a 5.55% increase year-over-year.
- CASTLE BIOSCIENCES, INC. increase (decrease) in employee related liabilities for fiscal 2025 was $5.73M, a 58.78% increase from fiscal 2024.
- CASTLE BIOSCIENCES, INC. increase (decrease) in employee related liabilities for fiscal 2024 was $3.61M, a 21.30% decline from fiscal 2023.
- CASTLE BIOSCIENCES, INC. increase (decrease) in employee related liabilities for fiscal 2023 was $4.59M, a 46.00% decline from fiscal 2022.
- CASTLE BIOSCIENCES, INC. increase (decrease) in employee related liabilities for fiscal 2022 was $8.49M, a 36.84% increase from fiscal 2021.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 6 month as first filed | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 9 month as first filed | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$11.39M 10-Q · filed 2026-07-30 | -$4.87M derived: sum of 3 quarters · filed 2026-07-30 | $1.92M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | -$19.18M 10-Q · filed 2026-05-06 | -$12.65M derived: sum of 2 quarters · filed 2026-05-06 | -$5.86M derived: sum of 3 quarters · filed 2026-05-06 | $1.25M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | $6.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $13.31M derived: sum of 2 quarters · filed 2026-02-26 | $20.43M derived: sum of 3 quarters · filed 2026-07-30 | $5.73M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $6.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $13.91M derived: sum of 2 quarters · filed 2026-07-30 | -$792.00K 10-Q · filed 2025-11-03 | $4.09M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | $7.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$7.58M 10-Q · filed 2026-07-30 | -$2.70M derived: sum of 3 quarters · filed 2026-07-30 | $3.73M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | -$14.70M 10-Q · filed 2026-05-06 | -$9.81M derived: sum of 2 quarters · filed 2026-05-06 | -$3.38M derived: sum of 3 quarters · filed 2026-05-06 | $3.15M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.32M derived: sum of 2 quarters · filed 2026-02-26 | $17.85M derived: sum of 3 quarters · filed 2026-02-26 | $3.61M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $6.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $12.96M derived: sum of 2 quarters · filed 2025-11-03 | -$1.27M 10-Q · filed 2025-11-03 | $5.27M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $6.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$7.71M 10-Q · filed 2025-08-04 | -$1.17M derived: sum of 3 quarters · filed 2026-02-26 | $3.94M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | -$14.24M 10-Q · filed 2025-05-05 | -$7.70M derived: sum of 2 quarters · filed 2026-02-26 | -$2.59M derived: sum of 3 quarters · filed 2026-02-26 | $1.91M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.65M derived: sum of 2 quarters · filed 2026-02-26 | $16.15M derived: sum of 3 quarters · filed 2026-02-26 | $4.59M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $5.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $9.61M derived: sum of 2 quarters · filed 2024-11-04 | -$1.95M 10-Q · filed 2024-11-04 | $2.87M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$7.06M 10-Q · filed 2024-08-05 | -$2.23M derived: sum of 3 quarters · filed 2025-02-27 | $2.45M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | -$11.56M 10-Q · filed 2024-05-02 | -$6.74M derived: sum of 2 quarters · filed 2025-02-27 | -$2.05M derived: sum of 3 quarters · filed 2025-02-27 | $3.85M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $9.51M derived: sum of 2 quarters · filed 2025-02-27 | $15.41M derived: sum of 3 quarters · filed 2025-02-27 | $8.49M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $4.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $10.59M derived: sum of 2 quarters · filed 2023-11-02 | $3.67M 10-Q · filed 2023-11-02 | $6.87M derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | $5.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$1.01M 10-Q · filed 2023-08-02 | $2.18M derived: sum of 3 quarters · filed 2023-08-02 | $5.72M derived: sum of 4 quarters · filed 2023-08-02 | ||
| 2022-03-31 | -$6.92M 10-Q · filed 2023-05-03 | -$3.72M derived: sum of 2 quarters · filed 2023-05-03 | -$186.00K derived: sum of 3 quarters · filed 2023-05-03 | $3.19M derived: sum of 4 quarters · filed 2023-05-03 | ||
| 2021-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $6.73M derived: sum of 2 quarters · filed 2023-02-28 | $10.11M derived: sum of 3 quarters · filed 2023-02-28 | $6.21M 10-K · filed 2023-02-28 | ||
| 2021-09-30 | $3.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $6.91M derived: sum of 2 quarters · filed 2022-11-02 | $3.01M 10-Q · filed 2022-11-02 | $5.77M derived: sum of 4 quarters · filed 2022-11-02 | ||
| 2021-06-30 | $3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$523.00K 10-Q · filed 2022-08-08 | $2.23M derived: sum of 3 quarters · filed 2022-08-08 | $3.93M derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | -$3.90M 10-Q · filed 2022-05-09 | -$1.15M derived: sum of 2 quarters · filed 2022-05-09 | $557.00K derived: sum of 3 quarters · filed 2022-05-09 | $2.08M derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $4.46M derived: sum of 2 quarters · filed 2022-02-28 | $5.97M derived: sum of 3 quarters · filed 2022-02-28 | $3.33M 10-K · filed 2022-02-28 | ||
| 2020-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $3.22M derived: sum of 2 quarters · filed 2021-11-08 | $575.00K 10-Q · filed 2021-11-08 | $2.68M derived: sum of 4 quarters · filed 2021-11-08 | ||
| 2020-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$1.13M 10-Q · filed 2021-08-09 | $976.00K derived: sum of 3 quarters · filed 2021-08-09 | $1.87M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | -$2.65M 10-Q · filed 2021-05-10 | -$542.00K derived: sum of 2 quarters · filed 2021-05-10 | $349.00K derived: sum of 3 quarters · filed 2021-05-10 | $372.00K derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $2.99M derived: sum of 2 quarters · filed 2021-03-11 | $3.02M derived: sum of 3 quarters · filed 2021-03-11 | $1.21M 10-K · filed 2021-03-11 | ||
| 2019-09-30 | $891.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $914.00K derived: sum of 2 quarters · filed 2020-11-09 | -$895.00K 10-Q · filed 2020-11-09 | -$894.85K 10-Q · filed 2019-11-12 | -$564.01K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$1.79M 10-Q · filed 2020-08-10 | -$1.79M 10-Q · filed 2019-09-03 | -$1.46M derived: sum of 3 quarters · filed 2020-08-10 | -$770.47K derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | -$1.81M 10-Q · filed 2020-05-11 | -$1.48M derived: sum of 2 quarters · filed 2020-05-11 | -$793.47K derived: sum of 3 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $330.99K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $1.02M derived: sum of 2 quarters · filed 2020-03-10 | $1.35M 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $684.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.02M 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $331.46K 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |